Paul K. Paik, Egbert F. Smit, Hélène Senellart, Rémi Veillon, Juergen Alt, Ingel Demedts, Hovav Nechushtan, Jianhua Shi, Christopher Stroh, Dilafruz Juraeva, Marie-Noelle Solbes, Rolf Bruns, Andreas Johne, Terufumi Kato. "Profiling patients with
                    <i>MET</i>
                    exon 14 (
                    <i>MET</i>
                    ex14) skipping NSCLC with a sustained clinical benefit to tepotinib in VISION.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8612